Tecentriq

atezolizumab · Genentech, a Roche company

Drug timelines are a Plus or Pro feature.

162 regulatory and trial events tracked for Tecentriq, covering 2016-05-18 to 2026-07-21. Get the full timeline:

Most recent: EMA Authorised: Tecentriq (atezolizumab) — Roche Registration GmbH